What are the indications and dosing regimens for ASTEPRO 0.15% compared to other nasal azelastine products?
ASTEPRO 0.15% is the first nasal antihistamine with an indication for SAR (once or twice-daily dosing) and PAR (twice-daily dosing). ASTEPRO is indicated for the relief of symptoms of seasonal allergic rhinitis in patients 12 years and older and dosed BID. Nasal Azelastine Products SAR PAR QD (SAR) BID ASTEPRO 0.